Table 3 The active sites amino acids.

From: In vivo, in silico effects of sakuranetin as a multi-target nutraceutical against PTZ-induced seizures via GABA restoration and BDNF/TrkB activation

PDB ID

Active sites amino acids

1B8M

TYR54, TYR96, VAL112, LEU113, GLY114, VAL115, LEU116, VAL118, LEU120, GLN97, GLN98, PHE102, and PHE103

4AT3

LEU560A, PHE565A, ALA586A, PHE633A, GLU634A, TYR635A, MET636A, LYS637A, GLY639A, ASN697A, LEU699A, GLY709A, ASP710A

6CM4

TRP100A, PHE110A, ASP114A, VAL115A, CYS118A, THR119A, ALA122A, SER197A, PHE198A, PHE382A, TRP386A, PHE389A, PHE390A, TYR408A, THR412A, TYR416A